Pacer Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
BG
AIM
NAMA
FAM
Pacer Advisors's CDNA Position: Q3 2024 in Review
Pacer Advisors sold out of CareDx (CDNA) in Q3 2024, closing a stake of 509 shares — an estimated $7.91K sold.
Pacer Advisors first reported a position in CDNA in Q3 2018 and held it in 6 quarters. The position peaked at $139K in Q4 2020. 215 funds tracked by Wall St. Rank hold CDNA as of Q3 2024.
- Pacer Advisors reported no remaining CareDx position as of Q3 2024 after selling out during the quarter.
- Pacer Advisors sold 509 CareDx shares in Q3 2024, an estimated $7.91K.
- Pacer Advisors first reported a position in CareDx in Q3 2018 and held it in 6 quarters.
- Pacer Advisors's CareDx position peaked at $139K in Q4 2020.
- 215 funds tracked by Wall St. Rank held CareDx as of Q3 2024.
Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.